Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PAPAVmed Inc. logo

PAVmed Inc. (PAVM)

NASDAQ Capital Market · Currency in USD
$2.17 ▲ +0.12 (+5.85%)
At close: Oct 23, 4:00 PM ET. Market closed.
$2.17 ▲ +0.00 (+0.00%)
After hours: Oct 23, 7:30 PM ET

Summary

Previous Close
$2.05
Open
$2.28
Day's Range
$1.84 – $2.30
52 Week Range
$1.84 – $28.44
Volume
28,411
Avg. Volume
27,939
Market Cap
$17.35M
Beta (5Y Monthly)
0.54
PE Ratio (TTM)
--
EPS (TTM)
-$1.93
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: PAVmed Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
41
CEO
Lishan Aklog
Website
pavmed.com

PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.63 · Revenue est. $25.00K
DateEst.Actual
Aug 14, 2026-$0.47-$0.87Miss
May 15, 2026-$0.69-$4.42Miss
Mar 26, 2026-$4.50-$2.05Beat
Nov 13, 2025-$5.10-$8.70Miss
Aug 14, 2025-$3.90-$22.20Miss
May 14, 2025-$8.71-$2.10Beat

Analyst view

Rating: Buy
Buy 67% · Hold 33% · Sell 0%

Get free alerts on PAVM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.